Cangene gains on vaccine approval

Cangene Corp. (TSX:CNJ) gained C$0.26 (17%) to C$1.78 on Friday after FDA approved the company's Varizig to reduce the severity of Varicella zoster virus (VZV) infection in high risk individuals when ...